Form 4: Vita Coco CFO Exercises, Sells Shares Under 10b5-1 Plan

Corey Baker, CFO of Vita Coco Company, Inc., exercised stock options and subsequently sold common stock under a Rule 10b5-1 trading plan.

Summary

• Corey Baker, Chief Financial Officer of Vita Coco Company, Inc. (COCO), reported transactions involving the exercise of stock options and the subsequent sale of common stock.
• On September 16, 17, and 18, 2025, Baker exercised non-qualified stock options to acquire 1,000 shares of common stock each day at an exercise price of $16.91 per share.
• Concurrently, on each of these three days, Baker sold 1,000 shares of common stock at a price of $40.00 per share.
• These sales were executed pursuant to a pre-arranged Rule 10b5-1 trading plan.
• Following these transactions, Baker's direct beneficial ownership of common stock decreased by 1,000 shares from 39,754 to 38,754 on each transaction day, as the acquired shares were immediately sold.
• Baker continues to hold various tranches of non-qualified stock options with exercise prices ranging from $16.91 to $33.36, subject to different vesting schedules and expiration dates.

Sentiment

Score: 6

Explanation: The filing details routine insider transactions by the CFO under a pre-arranged 10b5-1 trading plan. While insider selling can sometimes be viewed cautiously, the pre-planned nature and the monetization of vested equity are generally neutral to slightly positive events, reflecting executive compensation practices.

Positives

• The CFO monetized vested equity, realizing a gain of $23.09 per share ($40.00 sale price $16.91 exercise price) for 3,000 shares, totaling $69,270 over three days.
• Transactions were conducted under a Rule 10b5-1 trading plan, indicating a pre-scheduled, non-discretionary sale, which can mitigate concerns about opportunistic insider selling.

Negatives

• The sale of shares by a key executive, even under a 10b5-1 plan, could be interpreted by some as a lack of conviction, although this is a routine part of executive compensation and liquidity management.

Risks

• No specific risks related to the company's operations or financial health are disclosed in this Form 4 filing, as it primarily reports insider transactions.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This filing reports routine insider transactions and does not provide information directly related to broader industry trends or competitive landscape for Vita Coco Company, Inc.

Stakeholder Impact

• Shareholders: The transactions represent a routine monetization of vested equity by a key executive, which is a common practice and generally has minimal direct impact on other shareholders. The sales were pre-planned, reducing concerns about opportunistic selling.
• Employees: No direct impact on employees is indicated by this filing.

Next Steps

• Continued vesting of remaining non-qualified stock options held by Corey Baker according to their respective schedules.

Key Dates

Recommendation

The filing details routine insider transactions by the CFO under a pre-arranged 10b5-1 trading plan. These transactions are generally not indicative of a change in company fundamentals or management's long-term outlook, thus a 'hold' recommendation is appropriate based solely on this filing.

Keywords

Vita Coco, COCO, Corey Baker, CFO, Form 4, Insider Trading, Stock Options, Rule 10b5-1, Equity Sales, Beneficial Ownership